ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy

BACKGROUND: Patients with hepatocellular carcinoma (HCC) may develop end-stage renal disease and receive dialysis, but the impact of dialysis on the prognosis is unclear. This study aimed to evaluate the outcome of dialysis HCC patients and the prognostic role of albumin-bilirubin (ALBI) grade in th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Gastrointest Oncol
Prif Awduron: Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Ko, Chih-Chieh, Huang, Yi-Hsiang, Su, Chien-Wei, Hsia, Cheng-Yuan, Lee, Rheun-Chuan, Hou, Ming-Chih, Huo, Teh-Ia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2021
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107592/
https://ncbi.nlm.nih.gov/pubmed/34012661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-332
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg